113 related articles for article (PubMed ID: 10809021)
1. 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication.
Akanitapichat P; Lowden CT; Bastow KF
Antiviral Res; 2000 Feb; 45(2):123-34. PubMed ID: 10809021
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activity.
Goodell JR; Madhok AA; Hiasa H; Ferguson DM
Bioorg Med Chem; 2006 Aug; 14(16):5467-80. PubMed ID: 16713270
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1,3-dihydroxyacridone and 1,3,7-trihydroxyacridone.
Vance JR; Bastow KF
Biochem Pharmacol; 1999 Aug; 58(4):703-8. PubMed ID: 10413309
[TBL] [Abstract][Full Text] [Related]
4. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives.
Lowden CT; Bastow KF
Antiviral Res; 2003 Aug; 59(3):143-54. PubMed ID: 12927304
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of topoisomerase II by ICRF-193 prevents efficient replication of herpes simplex virus type 1.
Hammarsten O; Yao X; Elias P
J Virol; 1996 Jul; 70(7):4523-9. PubMed ID: 8676478
[TBL] [Abstract][Full Text] [Related]
6. Anti-herpes simplex virus activity of substituted 1-hydroxyacridones.
Lowden CT; Bastow KF
J Med Chem; 2003 Nov; 46(23):5015-20. PubMed ID: 14584951
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative actions of 7-substituted 1,3-dihydroxyacridones; possible involvement of DNA topoisomerase II and protein kinase C as biochemical targets.
Bastow KF; Itoigawa M; Furukawa H; Kashiwada Y; Bori ID; Ballas LM; Lee KH
Bioorg Med Chem; 1994 Dec; 2(12):1403-11. PubMed ID: 7788303
[TBL] [Abstract][Full Text] [Related]
8. The antiviral agent 5-chloro-1,3-dihydroxyacridone interferes with assembly and maturation of herpes simplex virus.
Akanitapichat P; Bastow KF
Antiviral Res; 2002 Feb; 53(2):113-26. PubMed ID: 11750937
[TBL] [Abstract][Full Text] [Related]
9. Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.
Oppegard LM; Ougolkov AV; Luchini DN; Schoon RA; Goodell JR; Kaur H; Billadeau DD; Ferguson DM; Hiasa H
Eur J Pharmacol; 2009 Jan; 602(2-3):223-9. PubMed ID: 19071108
[TBL] [Abstract][Full Text] [Related]
10. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
12. Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase IIα.
Infante Lara L; Sledge A; Laradji A; Okoro CO; Osheroff N
Bioorg Med Chem Lett; 2017 Feb; 27(3):586-589. PubMed ID: 27998679
[TBL] [Abstract][Full Text] [Related]
13. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
14. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
15. HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses.
Yan Z; Bryant KF; Gregory SM; Angelova M; Dreyfus DH; Zhao XZ; Coen DM; Burke TR; Knipe DM
mBio; 2014 Jul; 5(4):e01318-14. PubMed ID: 24987091
[TBL] [Abstract][Full Text] [Related]
16. New acridone inhibitors of human herpes virus replication.
Bastow KF
Curr Drug Targets Infect Disord; 2004 Dec; 4(4):323-30. PubMed ID: 15578973
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, DNA and protein interactions and human topoisomerase inhibition of novel Spiroacridine derivatives.
Gouveia RG; Ribeiro AG; Segundo MÂSP; de Oliveira JF; de Lima MDCA; de Lima Souza TRC; de Almeida SMV; de Moura RO
Bioorg Med Chem; 2018 Dec; 26(22):5911-5921. PubMed ID: 30420325
[TBL] [Abstract][Full Text] [Related]
18. Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome.
Benson JD; Huang ES
J Virol; 1988 Dec; 62(12):4797-800. PubMed ID: 2846890
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus 1 activates cdc2 to recruit topoisomerase II alpha for post-DNA synthesis expression of late genes.
Advani SJ; Weichselbaum RR; Roizman B
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4825-30. PubMed ID: 12665617
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
